Other SOCs, such as vascular disorders (n = 553, 1.25%), eye disorders (n = 413, 0.93%), cardiac disorders (n = 320, 0.72%), and metabolism and nutrition disorders (n = 384, 0.87%), were not listed in the drug's label but warrant attention for potential preventive measures. The gene discussed is CISH; the disease is eye disorder.